Renal Cancers Completed Phase 1 Trials for Sunitinib (DB01268)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00422344A Study of RAD001 and Sunitinib in Metastatic Renal Cell CarcinomaTreatment
NCT00421512A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma PatientsTreatment
NCT01122615Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)Treatment
NCT00399152Perifosine + Sunitinib Malate for Patients With Advanced CancersTreatment